Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment

Biol Psychiatry. 1997 Aug 1;42(3):175-80. doi: 10.1016/S0006-3223(96)00338-1.

Abstract

The prolactin (PRL) responses to oral d-fenfluramine (30 mg) and placebo were assessed in 13 patients with obsessive-compulsive disorder (OCD) and in matched healthy subjects. After the neuroendocrine test, all patients were treated with fluvoxamine maleate (150-300 mg/day). At the end of the 10th week of treatment, 10 patients underwent again the neuroendocrine assessment. In drug-free patients, the PRL response to d-fenfluramine was significantly lower than in the comparison group. After 10-week fluvoxamine treatment, the PRL response to the serotonergic agent normalized. These findings suggest that, at least at the neuroendocrine level, central serotonergic responsivity is reduced in drug-free OCD patients, and that long-term fluvoxamine administration is associated with its normalization.

MeSH terms

  • Adolescent
  • Adult
  • Brain / drug effects
  • Brain / physiopathology
  • Female
  • Fenfluramine*
  • Fluvoxamine / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Obsessive-Compulsive Disorder / blood
  • Obsessive-Compulsive Disorder / diagnosis
  • Obsessive-Compulsive Disorder / drug therapy*
  • Prolactin / blood*
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*
  • Serotonin / physiology
  • Serotonin Agents*

Substances

  • Serotonin Agents
  • Serotonin Uptake Inhibitors
  • Fenfluramine
  • Serotonin
  • Prolactin
  • Fluvoxamine